Back to News
Market Impact: 0.3
Moderna Stock Is Soaring: What's Going On?
Source: benzinga.com
Healthcare & BiotechProduct Launches
Moderna shares surged Monday after three abstracts on its personalized cancer vaccine, intismeran autogene, were accepted for presentation at the European Society for Medical Oncology Congress. The accepted abstracts provide a near-term scientific catalyst and could support investor confidence in Moderna's oncology pipeline.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.42
Ticker Sentiment
MRNA0.62
More News
- Moderna’s Bob Langer and AI pioneer Yann LeCun join board of Cellular Intelligence, bringing AI into medicine via a Parkinson’s drug
- GRAIL Stock Bounces Back Above $100: Can Galleri Sail Through Its FDA Panel Review?
- Meta's Muse personal AI agent tops ChatGPT, Grok and Claude for post-launch downloads
- Muse, Meta's extraordinarily privileged AI assistant, has a serious 0-day
- Ra Capital Management sells $21.8m in Sionna Therapeutics shares
- Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production